Biomarin Pharmaceutical (BMRN) Exchange Rate Effect (2014 - 2026)

Biomarin Pharmaceutical has disclosed Exchange Rate Effect across 13 years of filings, most recently posting $1.4 million for Q1 2026.

• Quarterly Exchange Rate Effect rose 199.58% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $305000.0 (down 79.49% YoY) and the FY2025 annual result came in at -$2.5 million, down 152.19% from the prior year.
• Exchange Rate Effect climbed to $1.4 million in Q1 2026, from $1.2 million in the prior quarter.
• Over five years, Exchange Rate Effect peaked at $3.3 million in Q2 2024 and troughed at -$3.6 million in Q4 2023.
• A 5-year average of $297588.2 and a median of $739000.0 in 2025 frame the typical range for Exchange Rate Effect.
• Biggest YoY gain for Exchange Rate Effect was 814.81% in 2023; the steepest drop was 5236.62% in 2023.
• Tracing BMRN's Exchange Rate Effect over 5 years: stood at $71000.0 in 2022, then plunged by 5236.62% to -$3.6 million in 2023, then surged by 168.66% to $2.5 million in 2024, then plunged by 51.32% to $1.2 million in 2025, then grew by 15.67% to $1.4 million in 2026.
• Business Quant data shows BMRN's Exchange Rate Effect at $1.4 million in Q1 2026, $1.2 million in Q4 2025, and $739000.0 in Q3 2025.